Representative before the EPO

Company dna inserm transfert ip department 7 rue watt
no operation time available
Headquarter in Paris
Technology Transfer Office

Matthieu Collin has worked on the following 73 EPO patent applications which have been published in the last five years:

EP14721259

METHODS AND KITS FOR TESTING THE GENOTOXICITY OF AN AGENT

IPC classification:
G01N 33/50
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Rouen
Applicant:
Centre Hospitalier Universitaire de Rouen
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14718603

METHODS FOR STIMULATING ANTIGEN-SPECIFIC T CELL RESPONSES

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14725123

FGF23 AS A BIOMARKER FOR PREDICTING THE RISK OF MORTALITY DUE TO END STAGE LIVER DISEASE

IPC classification:
G01N 33/74
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14728216

BIOMARKER OF REHOSPITALIZATION AFTER HEART FAILURE

IPC classification:
G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre Hospitalier Universitaire de Toulouse
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14726637

USE OF URINARY HIV NUCLEIC ACIDS TO DIAGNOSE AND MONITOR HIV-ASSOCIATED NEPHROPATHY (HIVAN)

IPC classification:
C12Q 1/70
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14729335

ANTI-HER2 SINGLE DOMAIN ANTIBODIES, POLYPEPTIDES COMPRISING THEREOF AND THEIR USE FOR TREATING CANCER

IPC classification:
A61K 39/00, C07K 16/32
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14730859

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA

IPC classification:
A61K 31/7125, A61P 7/00, A61P 17/00, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14735542

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 38/20, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14735525

INTERLEUKIN 15 (IL-15) ANTAGONISTS AND USES THEREOF FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES

IPC classification:
A61K 38/20, C07K 14/54, C12N 15/00, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Nantes
Applicant:
Université d'Angers
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14733199

METHODS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE RETINA OF A SUBJECT

IPC classification:
C07K 14/47, C12N 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14735579

NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF

IPC classification:
A61K 38/00, C07K 14/47, C12N 5/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Nantes
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14737236

METHODS FOR PERFORMING ANTISENSE OLIGONUCLEOTIDE-MEDIATED EXON SKIPPING IN THE RETINA OF A SUBJECT IN NEED THEREOF

IPC classification:
A61K 31/7088, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14744575

METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS

IPC classification:
G01N 33/569
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14741881

ANTI-CLAUDIN 1 ANTIBODIES FOR USE IN THE TREATMENT OF COLORECTAL CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14746985

ANTI-CLAUDIN 1 ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14755794

IMMUNOADJUVANT COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/39
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14766458

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS

IPC classification:
A61K 31/712, A61P 11/00, A61P 43/00, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP14766503

LENTIVIRAL VECTORS HAVING A MUTATED INTEGRASE PROTEIN AND USES THEREOF

IPC classification:
C07K 14/005, C12N 15/86
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14766481

METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY

IPC classification:
A61K 31/513, A61P 25/08
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
GRANT OF PATENT INTENDED
EP14786873

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF POLYOMAVIRUS INFECTIONS

IPC classification:
A61K 31/7068, A61P 13/12, A61P 31/20, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Ecole Normale Supérieure de Lyon
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Claude Bernard Lyon I (UCBL)
Applicant:
Les Hospices Civils de Lyon
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP13836207

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCERS

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14799415

A RHO GTPASE ACTIVATOR FOR USE AS ANTIMICROBIAL AGENT

IPC classification:
A61K 38/16, A61K 39/39, A61P 31/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Centre Hospitalier Universitaire de Nice
Applicant:
University of Nice (Université Nice Sophia Antipolis)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14808905

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIAS

IPC classification:
A61K 31/396, A61P 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14833136

METHODS FOR THE PREVENTION AND TREATMENT OF DIABETIC CARDIOMYOPATHY USING MIR-424/322

IPC classification:
A61K 48/00, C12N 15/864
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP14824852

COMBINATION OF AN ARSENIC COMPOUND AND AT LEAST ONE RETINOID FOR TREATING ACUTE MYELOID LEUKEMIA

IPC classification:
A61K 31/203, A61K 31/285, A61K 33/36, A61P 35/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION IN PROGRESS
EP15703742

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

IPC classification:
A61K 31/47, A61K 31/4709, A61K 38/17, A61K 38/22, A61K 39/00, A61K 45/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15703741

METHODS FOR THE PREVENTION AND THE TREATMENT OF EXTRACAPILLARY GLOMERULONEPHRITIS

IPC classification:
A61K 31/713, A61P 13/12, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15702743

SOLUBLE MONOMERIC ANTI-MULLERIAN HORMONE RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF

IPC classification:
C07K 14/71, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15705274

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 31/7032, A61K 39/00, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université Lille 1 Sciences et Technologies
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15704806

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES MEDIATED BY THE NRP-1/OBR COMPLEX SIGNALING PATHWAY

IPC classification:
G01N 33/50, G01N 33/574
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Commissariat à l'Énergie Atomique et aux Énergies Alternatives
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université de Bourgogne Dijon
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15705594

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

IPC classification:
C07K 14/47, C12N 15/62
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15708510

CARBAPENEMASE AND ANTIBACTERIAL TREATMENT

IPC classification:
C12N 9/86
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15709213

DIAGNOSIS METHOD FOR LUPUS

IPC classification:
G01N 33/564
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15708545

METHODS AND KITS FOR CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCLs) INTO GCB-DLBCLs OR INTO ABC-DLBCLs

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Rouen
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15710188

METHODS FOR PREDICTING ACUTE REJECTION IN HEART RECIPIENTS

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15710530

A METHOD FOR INDUCING HUMAN CHOLANGIOCYTE DIFFERENTIATION

IPC classification:
C12N 5/071
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15711162

TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS EPAC1 INHIBITORS FOR THE TREATMENT OF MYOCARDIAL INFARCTION INJURY

IPC classification:
A61K 31/47, A61K 45/06, A61P 9/10
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15713503

AN ISOLATED DONOR MHC-DERIVED PEPTIDE AND USES THEREOF

IPC classification:
C07K 14/435
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Nantes
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15716069

ANTIBODIES FOR THE PREVENTION OR THE TREATMENT OF BLEEDING EPISODES

IPC classification:
A61K 39/395, A61P 7/04, C07K 16/36
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Droit et de la Santé de Lille 2
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15715758

POLYPEPTIDES AND USES THEREOF FOR REDUCING CD95-MEDIATED CELL MOTILITY

IPC classification:
C07K 14/435
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Applicant:
Université de Bordeaux
Applicant:
University of Nottingham
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15718902

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS

IPC classification:
A61K 38/17, A61K 38/43, A61K 38/46, A61P 7/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15723913

MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION

IPC classification:
A61K 31/423, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15723721

ANTI- EGFR CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15726593

ANTI-NEUROTENSIN LONG FRAGMENT ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/18, C07K 16/30
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15726633

PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES

IPC classification:
A61K 38/16, C07K 14/005
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
ICM - Institut du Cerveau et da la Moelle Epinière
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731531

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

IPC classification:
A61K 31/165, A61P 35/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Paris Descartes University (Université Paris Descartes - Paris V)
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15728015

METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER

IPC classification:
G01N 33/574
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bourgogne Dijon
Agent:
Cabinet Plasseraud
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731951

METHODS EMPLOYING CIRCULATING DNA AND MIRNA AS BIOMARKERS FOR FEMALE INFERTILITY

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731937

FREE NUCLEIC ACIDS AND MIRNA AS NON-INVASIVE METHOD FOR DETERMINING EMBRYO QUALITY

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15735940

A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION

IPC classification:
A61K 39/00, G01N 33/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Applicant:
Université Paris 6 Pierre et Marie Curie (UPMC)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15734409

METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIC PAIN

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15738898

METHODS FOR THE INTERCELLULAR TRANSFER OF ISOLATED MITOCHONDRIA IN RECIPIENT CELLS

IPC classification:
A61K 35/12, C12N 5/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of Montpellier (Université de Montpellier)
Applicant:
Centre Hospitalier Universitaire de Montpellier
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15738908

AN ISOLATED INTERLEUKIN-34 POLYPEPTIDE FOR USE IN PREVENTING TRANSPLANT REJECTION AND TREATING AUTOIMMUNE DISEASES

IPC classification:
A61K 38/20, A61P 37/06
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Nantes
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15731560

PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF OREXIN-1 RECEPTOR OX1R FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

IPC classification:
A61K 38/17, A61K 38/22, A61P 1/04, A61K 47/56
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
EXAMINATION REQUESTED
EP15760171

METHODS OF DIAGNOSING AND TREATING CANCER

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paul Sabatier Toulouse III
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15766500

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS

IPC classification:
A61K 31/435, A61K 31/496, A61K 45/00, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made
EP15780771

IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/28
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Matthieu Collin, Inserm Transfert
Status:
Request for examination was made

Please Sign in to use this feature